Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Prevalence and Potential Benefits of Fecal Immunochemical Test Before Ana After Use of Antiplatelet and Anticoagulant Agents

NCT07327853 is registered in ClinicalTrials.gov with Jordan Collaborating Cardiology Group as lead sponsor.

NCT NCT07327853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07327853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Prevalence and Potential Benefits of Fecal Immunochemical Test Before Ana After Use of Antiplatelet and Anticoagulant Agents
Lead sponsor
Jordan Collaborating Cardiology Group
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
April 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet agents, gastrointestinal bleeding, oral anticoagulant therapy